-
Zomepirac Sodium
-
BD15742464092-48-498+%
-
¥408.0250mg
-
14-Methyl-5-oxo-7,8-dihydro-5H-indolo[2',3':3,4]pyrido[2,1-b]quinazolin-14-ium-13-ide
-
BD20826167909-49-399+%
-
¥
-
N-(3-(5-(2-Hydroxypropan-2-yl)-1,2,4-oxadiazol-3-yl)benzyl)-2-(pyridin-2-yl)pyrimidine-5-carboxamide
-
BD6300351234708-04-398%
-
¥4500.010mg
-
(S)-2-(2-Fluoro-[1,1'-biphenyl]-4-yl)propanoic acid
-
BD2115051543-39-698%
-
¥1629.0250mg
-
2-(1,3,4-Triphenyl-1H-pyrazol-5-yl)acetic acid
-
BD13513550270-33-298%
-
¥
-
(E)-7-((1R,2R,3R)-3-Hydroxy-2-((3S,5S,E)-3-hydroxy-5-methylnon-1-en-1-yl)-5-oxocyclopentyl)hept-2-enoic acid
-
BD13634674397-12-998%
-
¥1208.05mg
-
14-Methyl-8,14-dihydroindolo[2',3':3,4]pyrido[2,1-b]quinazolin-5(7H)-one hydrochloride
-
BD298331111664-82-595%
-
¥214.05mg
-
4-(Benzo[b]thiophen-2-yl)-3-bromo-5-hydroxyfuran-2(5H)-one
-
BD427318938069-71-798%
-
¥2000.0100mg
-
HPGDS inhibitor 1
-
BD2171611033836-12-298%
-
¥2010.0100mg
-
2-(5H-Chromeno[2,3-b]pyridin-7-yl)propanoic acid
-
BD3392552549-17-498%
-
¥1549.05g
-
2-Hydroxy-4H-benzo[d][1,3,2]dioxabismin-4-one
-
BD11739614882-18-998%
-
¥45.025g
-
1-(4-(2H-Tetrazol-5-yl)butyl)-4-(5H-dibenzo[a,d][7]annulen-5-ylidene)piperidine
-
BD305637162640-98-498+%
-
¥661.025mg
-
2-(3,4-Dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one
-
BD12062306-27-695%
-
¥876.010mg
-
1-(4-chlorophenyl)-2,5-dimethyl-1h-pyrrole-3-aceticaci
-
BD5098442779-82-895%
-
¥2796.01g
-
(E)-3-(3,5-di-tert-butyl-4-hydroxybenzylidene)dihydrofuran-2(3H)-one
-
BD01137239102271-49-898%
-
¥
-
PF-9184
-
BD011542781221971-47-699+%
-
¥
-
mPGES-1-IN-1
-
BD014943772914158-00-098%
-
¥
-
BRP-201
-
BD015225662227434-74-298%
-
¥
-
Desoxo-narchinol A
-
BD0146490353859-06-698%
-
¥
-
UT-11
-
BD0228412398%
-
¥